1. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
2. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int.
3. Hunter, E. et al. First experience of COVID-19 screening of health-care workers in England. The Lancet 395, e77–e78 (2020).
4. Nguyen, L. H. et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health 5, e475–e483 (2020).
5. Houlihan, C. F. et al. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. The Lancet 396, e6–e7 (2020).
6. Office for National Statistics. Coronavirus (COVID-19) related deaths by occupation, England and Wales. Office for National Statistics website https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/bulletins/coronaviruscovid19relateddeathsbyoccupationenglandandwales/deathsregisteredbetween9marchand28december2020 (2021).
7. Eyre, D. W. et al. Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. eLife 9, e60675 (2020).
8. Martin, C. A. et al. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff. J. Public Health Oxf. Engl. fdaa199 (2020) doi:10.1093/pubmed/fdaa199.
9. Shields, A. M. et al. COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals. J. Dent. Res. 00220345211020270 (2021) doi:10.1177/00220345211020270.
10. Valdes, A. M. et al. Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk. EClinicalMedicine 34, 100835 (2021).
11. Ken-Dror, G. et al. SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital. Clin. Med. 21, e290–e294 (2021).
12. Hanrath, A. T. et al. SARS-CoV-2 Testing of 11,884 Healthcare Workers at an Acute NHS Hospital Trust in England: A Retrospective Analysis. Front. Med. 8, 636160 (2021).
13. Shields, A. et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax 75, 1089–1094 (2020).
14. Shorten, R. J. et al. Seroprevalence of SARS-CoV-2 infection in healthcare workers in a large teaching hospital in the North West of England: a period prevalence survey. BMJ Open 11, e045384 (2021).
15. Patel, M., Nair, M., Pirozzoli, E., Cienfuegos, M. C. & Aitken, E. Prevalence and socio-demographic factors of SARS-CoV-2 antibody in multi-ethnic healthcare workers. Clin. Med. 21, e5–e8 (2021).
16. Kua, J. et al. healthcareCOVID: a national cross-sectional observational study identifying risk factors for developing suspected or confirmed COVID-19 in UK healthcare workers. PeerJ 9, e10891 (2021).
17. Chaudhuri, K., Chakrabarti, A., Lima, J. M., Chandan, J. S. & Bandyopadhyay, S. The interaction of ethnicity and deprivation on COVID-19 mortality risk: a retrospective ecological study. Sci. Rep. 11, 11555 (2021).
18. Ho, F. K. et al. Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open 10, e040402 (2020).
19. Asghar, Z. B., Ward, D., Huntly, P., Inghels, M. & Tanser, F. COVID-19 (SARS-CoV-2) Outbreaks in Rural United Kingdom: Patterns of Spread and Empirical Evidence for the ‘Rule of Six’. https://papers.ssrn.com/abstract=3807267 (2021) doi:10.2139/ssrn.3807267.
20. Public Health England. Disparities in the risk and outcomes of COVID-19. 92 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/908434/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdf.
21. Iacobucci, G. Covid-19: PHE review has failed ethnic minorities, leaders tell BMJ. BMJ 369, m2264 (2020).
22. Mathur, R. et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. The Lancet 397, 1711–1724 (2021).
23. Race Disparity Unit, Cabinet Office. Third quarterly report on progress to address COVID-19 health inequalities. GOV.UK https://www.gov.uk/government/publications/third-quarterly-report-on-progress-to-address-covid-19-health-inequalities/third-quarterly-report-on-progress-to-address-covid-19-health-inequalities (2021).
24. Yamamoto, N. et al. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene 758, 144944 (2020).
25. Lu, C., Gam, R., Pandurangan, A. P. & Gough, J. Genetic risk factors for death with SARS-CoV-2 from the UK Biobank. http://medrxiv.org/lookup/doi/10.1101/2020.07.01.20144592 (2020) doi:10.1101/2020.07.01.20144592.
26. Department of Health and Social Care [UK]. Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination, 30 December 2020. GOV.UK https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020 (2021).
27. Harrison, E. M. et al. Ethnicity and Outcomes from COVID-19: The ISARIC CCP-UK Prospective Observational Cohort Study of Hospitalised Patients. https://papers.ssrn.com/abstract=3618215 (2020) doi:10.2139/ssrn.3618215.
28. Kabarriti, R. et al. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York. JAMA Netw. Open 3, e2019795 (2020).
29. Piroth, L. et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir. Med. 9, 251–259 (2021).
30. Shields, A. M. et al. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response. MedRxiv Prepr. Serv. Health Sci. 2020.11.12.20230763 (2020) doi:10.1101/2020.11.12.20230763.
31. Rivett, L. et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife 9, e58728 (2020).
32. Martin, C. A. et al. Association of demographic and occupational factors with SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: a rapid real-world analysis. medRxiv 2021.02.11.21251548 (2021) doi:10.1101/2021.02.11.21251548.
33. Razai, M. S., Osama, T., McKechnie, D. G. J. & Majeed, A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ 372, n513 (2021).
34. Glampson, B. et al. North West London Covid-19 Vaccination Programme: Real-world evidence for Vaccine uptake and effectiveness. medRxiv 2021.04.08.21254580 (2021) doi:10.1101/2021.04.08.21254580.
35. Public Health England. COVID-19: management of staff and exposed patients or residents in health and social care settings. GOV.UK https://www.gov.uk/government/publications/covid-19-management-of-exposed-healthcare-workers-and-patients-in-hospital-settings/covid-19-management-of-exposed-healthcare-workers-and-patients-in-hospital-settings (2021).
36. Kaplan, E. L. & Meier, P. Nonparametric Estimation from Incomplete Observations. J. Am. Stat. Assoc. 53, 457–481 (1958).
37. Cox, D. R. Regression Models and Life-Tables. J. R. Stat. Soc. Ser. B Methodol. 34, 187–202 (1972).
38. Therneau, T. A package for survival analysis in R. (2021).
39. R Core Team. R: A language and environment for statistical computing. (R Foundation for Statistical Computing, 2021).